Cargando…
In Vitro and in Vivo Activity of mTOR Kinase and PI3K Inhibitors Against Leishmania donovani and Trypanosoma brucei
Kinetoplastid parasites, including Leishmania and Trypanosoma spp., are life threatening pathogens with a worldwide distribution. Next-generation therapeutics for treatment are needed as current treatments have limitations, such as toxicity and drug resistance. In this study, we examined the activit...
Autores principales: | Phan, Trong-Nhat, Baek, Kyung-Hwa, Lee, Nakyung, Byun, Soo Young, Shum, David, No, Joo Hwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221892/ https://www.ncbi.nlm.nih.gov/pubmed/32340370 http://dx.doi.org/10.3390/molecules25081980 |
Ejemplares similares
-
In Vivo Efficacy of SQ109 against Leishmania donovani, Trypanosoma spp. and Toxoplasma gondii and In Vitro Activity of SQ109 Metabolites
por: Baek, Kyung-Hwa, et al.
Publicado: (2022) -
Cellular landmarks of Trypanosoma brucei and Leishmania mexicana
por: Halliday, Clare, et al.
Publicado: (2019) -
Structural Modelling of Platelet Activating Factor Acetyl Hydrolase in Leishmania donovani, Trypanosoma cruzi, and Trypanosoma brucei: Implications on Therapeutics for Leishmaniasis, Chagas Disease, and Sleeping Sickness
por: Goswami, Arunima, et al.
Publicado: (2023) -
Overview of DNA Repair in Trypanosoma cruzi, Trypanosoma brucei, and Leishmania major
por: Passos-Silva, Danielle Gomes, et al.
Publicado: (2010) -
Retinoic Acid Increases Cellular Cholesterol in Leishmania donovani-Infected Macrophages in an mTOR-Independent Manner
por: Prakash, Satya, et al.
Publicado: (2022)